TooNiceStocks Initiates Coverage on BioSante Pharmaceuticals, Inc. Looming February 14th, 2012 FDA Decision with Elevated Interest

BioSante Pharmaceuticals is a development stage biotech company focusing on drugs for sexual health and oncology. TooNiceStocks research discovered the recent collapse in the company’s stock on December 14, 2011 from the day’s high of 2.60 to a low of 0.38 in after hours trading, have left many investors asking, "so what’s next for BioSante?" Since then, BioSante has slowly recovered somewhat, the stock is still trading at a much-reduced range of $.50, a substantial discount of roughly $52 million market cap compared to about $286 million before the news. However with one drug approved and another facing a regulatory decision in the form of a PDUFA on February 14th, 2012, smallcap investors are already gambling.

(PRWeb January 13, 2012)

Read the full story at

Survival Of Gynecological Cancer Improved In The Anglia Region Of England

Gynaecological cancer survival rates have improved in Eastern England following the reorganisation of services and multidisciplinary team working finds a new study published in the gynaecological oncology themed issue of BJOG: An International Journal of Obstetrics and Gynaecology…

HPV DNA Testing Advised For Females Over 30

HPV DNA testing is better than cytology alone in preventing cervical cancer or detecting it early on for women over thirty, researchers reported in The Lancet Oncology. The authors explained, after reporting on the POBASCAM trial, that they now have compelling evidence in favour of routine HPV testing in national screening programs…

Susquehanna Health Ahead of the Curve with Breast Density Cancer Screenings

Research published recently in the Journal of Clinical Oncology (JCO) and the Journal of the National Cancer Institute (JNCI) identifies breast density as being associated with an increased risk of breast cancer in post-menopausal women. These types of cancers are also noted to be more aggressive. Although reported findings are new, physicians at Susquehanna Health (SH) have been acting on this principle for nearly a decade. “Based on data and our experience, we instigated a screening process using whole breast ultrasound about seven years ago. So, we are way ahead of the curve, said Dr. Timothy Pagana, Medical Director of the SH Kathryn Candor Lundy Breast Health Center.

(PRWeb December 02, 2011)

Read the full story at

IUDs May Reduce Cervical Cancer Risk

Women who use intrauterine devices may not just be preventing pregnancy but may also be protecting themselves from cervical cancer, according to a new study involving more than 20,000 women in different countries that was published in The Lancet Oncology today…

Next Page »